These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 17593631)

  • 21. Protection of p53 wild type cells from taxol by genistein in the combined treatment of lung cancer.
    Tokalov SV; Abramyuk AM; Abolmaali ND
    Nutr Cancer; 2010; 62(6):795-801. PubMed ID: 20661829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms underlying the pro-survival pathway of p53 in suppressing mitotic death induced by adriamycin.
    Lin YC; Wang FF
    Cell Signal; 2008 Jan; 20(1):258-67. PubMed ID: 18006273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of p53 status in human cell lines using a functional assay in yeast: detection of new non-sense p53 mutation in codon 124.
    Smardová J; Pavlová S; Svitáková M; Grochová D; Ravcuková B
    Oncol Rep; 2005 Oct; 14(4):901-7. PubMed ID: 16142349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The novel platinum(IV) complex LA-12 induces p53 and p53/47 responses that differ from the related drug, cisplatin.
    Hrstka R; Powell DJ; Kvardova V; Roubalova E; Bourougaa K; Candeias MM; Sova P; Zak F; Fåhraeus R; Vojtĕsek B
    Anticancer Drugs; 2008 Apr; 19(4):369-79. PubMed ID: 18454047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of HIPK2 circumvents the blockade of apoptosis in chemoresistant ovarian cancer cells.
    Puca R; Nardinocchi L; Pistritto G; D'Orazi G
    Gynecol Oncol; 2008 Jun; 109(3):403-10. PubMed ID: 18395248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential effects of hypoxia on etoposide-induced apoptosis according to the cancer cell lines.
    Cosse JP; Sermeus A; Vannuvel K; Ninane N; Raes M; Michiels C
    Mol Cancer; 2007 Sep; 6():61. PubMed ID: 17894897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 7-Chloro-6-piperidin-1-yl-quinoline-5,8-dione (PT-262), a novel synthetic compound induces lung carcinoma cell death associated with inhibiting ERK and CDC2 phosphorylation via a p53-independent pathway.
    Hsu TS; Chen C; Lee PT; Chiu SJ; Liu HF; Tsai CC; Chao JI
    Cancer Chemother Pharmacol; 2008 Oct; 62(5):799-808. PubMed ID: 18193228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated p53 and p21waf1 mRNA expression in blood lymphocytes from lung cancer patients with chemoresistance.
    Shih CM; Chen K; Wang YC; Lee PJ; Wang YC
    Cancer Detect Prev; 2007; 31(5):366-70. PubMed ID: 18035504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential sensitivity of malignant glioma cells to methylating and chloroethylating anticancer drugs: p53 determines the switch by regulating xpc, ddb2, and DNA double-strand breaks.
    Batista LF; Roos WP; Christmann M; Menck CF; Kaina B
    Cancer Res; 2007 Dec; 67(24):11886-95. PubMed ID: 18089819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Doxorubicin and octreotide induce a 40 kDa breakdown product of p53 in human hepatoma and tumoral colon cell lines.
    Sadji-Ouatas Z; Lasfer M; Julien S; Feldmann G; Reyl-Desmars F
    Biochem J; 2002 Jun; 364(Pt 3):881-5. PubMed ID: 12049655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microtubule-damaging agents enhance RASSF1A-induced cell death in lung cancer cell lines.
    Whang YM; Park KH; Jung HY; Jo UH; Kim YH
    Cancer; 2009 Mar; 115(6):1253-66. PubMed ID: 19156899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Repression of SHP-1 expression by p53 leads to trkA tyrosine phosphorylation and suppression of breast cancer cell proliferation.
    Montano X
    Oncogene; 2009 Oct; 28(43):3787-800. PubMed ID: 19749791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Class III beta-tubulin mediates sensitivity to chemotherapeutic drugs in non small cell lung cancer.
    Gan PP; Pasquier E; Kavallaris M
    Cancer Res; 2007 Oct; 67(19):9356-63. PubMed ID: 17909044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Bcl-2/Bcl-XL family inhibitor ABT-737 sensitizes ovarian cancer cells to carboplatin.
    Witham J; Valenti MR; De-Haven-Brandon AK; Vidot S; Eccles SA; Kaye SB; Richardson A
    Clin Cancer Res; 2007 Dec; 13(23):7191-8. PubMed ID: 18056200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Arsenite enhances the benzo[a]pyrene diol epoxide (BPDE)-induced mutagenesis with no marked effect on repair of BPDE-DNA adducts in human lung cells.
    Chiang HC; Tsou TC
    Toxicol In Vitro; 2009 Aug; 23(5):897-905. PubMed ID: 19470404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Promoter methylation of O(6)-methylguanine-DNA-methyltransferase in lung cancer is regulated by p53.
    Lai JC; Cheng YW; Goan YG; Chang JT; Wu TC; Chen CY; Lee H
    DNA Repair (Amst); 2008 Aug; 7(8):1352-63. PubMed ID: 18555750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human 8-oxoguanine DNA glycosylase suppresses the oxidative stress induced apoptosis through a p53-mediated signaling pathway in human fibroblasts.
    Youn CK; Song PI; Kim MH; Kim JS; Hyun JW; Choi SJ; Yoon SP; Chung MH; Chang IY; You HJ
    Mol Cancer Res; 2007 Oct; 5(10):1083-98. PubMed ID: 17951408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Somatostatin enhances the chemosensitivity of GBC-SD cell line to doxorubicin through arresting the cell cycle to S phase rather than through the P53/Bax-depended apoptosis way in vitro.
    Songgang L; Jiyu L; Gongwei ; Yingbin L; Yiyu Q; Zhiwei Q
    Hepatogastroenterology; 2009; 56(94-95):1253-60. PubMed ID: 19950772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Relationship between the acquired multi-drug resistance of human large cell lung cancer cell line NCI-H460 by cisplatin selection and p53 mutation].
    Wang T; Xu J; Zhong NS
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):102-7. PubMed ID: 15854392
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiosensitization of p53-deficient lung cancer cells by pre-treatment with cytostatic compounds.
    Tokalov SV; Abolmaali N
    Anticancer Res; 2012 Apr; 32(4):1239-43. PubMed ID: 22493354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.